About Akero Therapeutics Akero Therapeutics is a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, including ...

Any thoughts on milk thistle supplements in fatty liver disease that was diagnosed by an ultrasound due to elevated AST and ...

When people hear about liver disease, most think it comes from excess alcohol consumption. However, one in four adults in the U.S. have a liver disease that is nonalcoholic, making it the most common ...

Findings offer a potential basis for sex-specific dietary guidelines for metabolic dysfunction–associated steatotic liver ...

Liver cancer is a lethal disease with limited treatment options for advanced stages. While risk factors such as viral ...

Rising cases of drug-induced liver injury (DILI) are raising concerns among health experts about the hidden dangers of common ...

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that the company will participate in the 46th Annual Global Goldman Sachs Health Care Conference on Wednesday, June 11, 2025 at 10:40 A.M.

A new American Diabetes Association consensus statement provides guidance on screening, diagnosing, and managing metabolic ...

Drug-induced liver injury cases are increasing, with common medications and supplements posing hidden dangers, especially for ...

New technology and drugs are transforming how doctors detect and treat silent liver disease MASLD before it leads to liver ...

Any thoughts on milk thistle supplements in fatty liver disease that was diagnosed by an ultrasound due to elevated AST and ...

NASH becomes MASH as medical experts replace stigmatizing "non-alcoholic" liver disease terminology with dignity-focused ...